Shannon Rourke Devens
Corporate Officer/Principal chez SURFACE ONCOLOGY, INC.
Profil
Shannon Rourke Devens is currently working as the Senior Vice President-Development Operation at Surface Oncology, Inc. Prior to this, Shannon worked as the Senior Director-Clinical Operations at Infinity Pharmaceuticals, Inc. Shannon holds a graduate degree from Northeastern University and an undergraduate degree from the University of Colorado Boulder.
Postes actifs de Shannon Rourke Devens
| Sociétés | Poste | Début |
|---|---|---|
| SURFACE ONCOLOGY, INC. | Corporate Officer/Principal | 15/12/2021 |
Anciens postes connus de Shannon Rourke Devens
| Sociétés | Poste | Fin |
|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Shannon Rourke Devens
| Northeastern University | Graduate Degree |
| University of Colorado Boulder | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company, which engages in the provision of biological pathways critical to the immunosuppressive tumor microenvironment for the development of next-generation cancer therapies. The firm’s pipeline includes wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114). Its pipeline also includes licensed product programs, such as a collaboration with Novartis targeting CD73 (NZV930, Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (SRF813, preclinical). The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA. | Health Technology |
